Small molecule inhibitors of Tnks disrupt Wnt signaling in cultured human cells and reduce colonic adenoma growth in mouse models, suggesting that Tnks is a promising therapeutic candidate for the treatment of Wnt-driven cancers [68,69,70,71,72,73]. The gene discussed is TNKS; the disease is colon adenoma.